IP Verse

A Process For Reduction And/Or Removal Of Fxi And Fxia From Solutions Containing Said Coagulation Factors

Patent No. EP2640413 (titled "A Process For Reduction And/Or Removal Of Fxi And Fxia From Solutions Containing Said Coagulation Factors") was filed by Octapharma on Nov 16, 2011. The application was issued on Jun 12, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
STRAWMANMar 12, 2020D YOUNG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2640413

OCTAPHARMA
Application Number
EP11784653A
Filing Date
Nov 16, 2011
Status
Opposition Rejected
Apr 28, 2023
Publication Date
Jun 12, 2019
External Links
Slate, Register , Google Patents